aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead...
Leadership
Sanjay S. Shukla M.D., M.S.
President, CEO & Director
Jill M. Broadfoot CPA
Chief Financial Officer
Nancy E. Denyes Krueger J.D.
General Counsel & Corporate Secretary
Ashlee Dunston
Director of Investor Relations & Corporate Communications
